23.68 - 23.68
20.75 - 25.07
1.4K / 5.9K (Avg.)
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
15.61%
Revenue growth exceeding 1.5x Insurance - Life median of 3.16%. Joel Greenblatt would verify if operating margins keep pace with this top-line surge.
15.61%
Gross profit growth exceeding 1.5x Insurance - Life median of 3.16%. Joel Greenblatt would check if cost advantages or brand equity drive this surge.
17.09%
EBIT growth exceeding 1.5x Insurance - Life median of 2.29%. Joel Greenblatt would examine whether a unique competitive edge supports this outperformance.
17.09%
Operating income growth exceeding 1.5x Insurance - Life median of 2.53%. Joel Greenblatt would see if unique processes drive exceptional profitability.
8.94%
Net income growth exceeding 1.5x Insurance - Life median of 4.93%. Joel Greenblatt would check if brand strength or cost advantages fuel this outperformance.
8.90%
EPS growth of 8.90% while Insurance - Life median is zero. Walter Schloss might see a slight edge that could compound over time.
8.98%
Diluted EPS growth of 8.98% while Insurance - Life median is zero. Walter Schloss might see a slight edge that could improve over time.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
73.91%
OCF growth of 73.91% while Insurance - Life is zero. Walter Schloss might see a modest positive difference, which can compound over time.
73.91%
FCF growth of 73.91% while Insurance - Life median is zero. Walter Schloss might see a slight edge that could compound over time.
138.15%
10Y revenue/share CAGR exceeding 1.5x Insurance - Life median of 34.92%. Joel Greenblatt would verify if a unique moat or brand fosters outperformance over a decade.
138.15%
5Y revenue/share growth exceeding 1.5x Insurance - Life median of 56.24%. Joel Greenblatt would see if the company’s moat drives rapid mid-term expansion.
92.78%
3Y revenue/share growth exceeding 1.5x Insurance - Life median of 23.19%. Joel Greenblatt might see a short-term competitive advantage at play.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
429.08%
3Y OCF/share growth > 1.5x Insurance - Life median of 43.82%. Joel Greenblatt might see a recent competitive advantage translating into cash improvements.
220.91%
Net income/share CAGR 1.25-1.5x Insurance - Life median. Mohnish Pabrai would confirm that management’s capital allocation strategy drives the outperformance.
220.91%
5Y net income/share CAGR > 1.5x Insurance - Life median of 137.38%. Joel Greenblatt might see superior mid-term capital allocation or product strength.
188.51%
3Y net income/share CAGR > 1.5x Insurance - Life median of 71.22%. Joel Greenblatt might see a recent surge from market share gains or cost synergy.
234.59%
Equity/share CAGR exceeding 1.5x Insurance - Life median of 5.46% over 10 years. Joel Greenblatt would see if a high ROE underlies this compounding advantage.
234.59%
5Y equity/share CAGR > 1.5x Insurance - Life median of 56.68%. Joel Greenblatt sees a possible ROE advantage or fewer share issuances boosting book value.
171.10%
3Y equity/share CAGR > 1.5x Insurance - Life median of 33.61%. Joel Greenblatt sees strong short-term returns on equity fueling net worth growth.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-3.66%
Assets shrink while Insurance - Life median grows. Seth Klarman might see a strategic refocus or potential missed expansion if demand is present.
-2.43%
Negative BV/share change while Insurance - Life median is 3.82%. Seth Klarman sees a firm-specific weakness if peers accumulate net worth.
-39.91%
Debt is shrinking while Insurance - Life median is rising. Seth Klarman might see an advantage if growth remains possible.
No Data
No Data available this quarter, please select a different quarter.
14.25%
SG&A growth of 14.25% while Insurance - Life median is zero. Walter Schloss sees a modest overhead increase needing revenue justification.